Company Profile
Our Mission and Future
YungShin Group has established a comprehensive presence across the pharmaceutical and health industry value chain. Our operations span upstream R&D and production of active pharmaceutical ingredients (APIs) and intermediates, midstream manufacturing of pharmaceutical products, health supplements, and animal-related products, as well as downstream distribution and sales of related finished goods. With this fully integrated business structure, we are committed to becoming one of the world’s leading companies in the health-related industries.
Enhancing Investment Efficiency and Development in the Pharmaceutical and Health-Related Industries
As an investment holding company, we maintain flexibility in adjusting our internal investments—strategically increasing or reducing our stake in subsidiaries to optimize resource allocation and operational efficiency. Externally, we actively pursue alliances, mergers, and acquisitions with companies in related industries to strengthen the Group’s overall competitiveness and expand our market share.
Integration of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms, and Control of the Supply Chain
From the early stages of its development, YungShin Group has invested in the research, development, and production of active pharmaceutical ingredients (APIs). The Group now operates dedicated API R&D and manufacturing divisions. Moving forward, we will continue to strengthen our vertically integrated supply chain and expand our portfolio of competitive API products across various regions through strategic collaborations, investments, mergers, and acquisitions.
Establishment and training of new generation talent
In response to market competition and the expanding demands of the health and wellness industry, the establishment and development of a high-level talent pool has become the cornerstone of the Group’s growth strategy. We have launched initiatives to recruit talents across production, sales, R&D, and finance, accompanied by comprehensive training, job rotation, and succession planning programs. These efforts aim to integrate next-generation mindsets, tools, and management practices into the organization. Building upon our current pharmaceutical foundation, we are actively expanding into related fields such as health and wellness, biotechnology, and other emerging industries.
Driving the Activation of Tangible and Intangible Assets Across the Group
We are actively promoting the revitalization of both tangible and intangible assets within the Group. In addition to guiding mature subsidiaries toward capital markets, we continuously assess and repurpose internal intangible assets to generate new value. These efforts aim to foster diversified growth in the health-related sectors and strengthen the Group’s long-term competitiveness.
Advancing ESG and Sustainable Investment Development
In addition to pursuing long-term corporate sustainability, YungShin Group actively promotes ESG-driven initiatives. Through platforms such as the Yung Shin Social Welfare Foundation, the TienTe Lee Biomedical Foundation, the Yung Shin Elderly Nursing Home, and the Yung Shin Cup- National Volleyball Tournament, we put our commitment to corporate social responsibility into action and contribute meaningfully to the community.
